| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.091 | 0.04 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |